Top Markets
#1 Islamic Coin Islamic Coin +151.57%
#2 Black Phoenix Black Phoenix +30.57%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.47%
#4 Palladium Network Palladium Network +17.37%
#5 Not in Employment, Education, or Training Not in Employment, Education, or Training +17.32%
#6 Fake World Assets Fake World Assets +14.46%
#7 clBTC clBTC +12.22%
#8 Akedo Akedo +12.02%
#9 Pons Pons +10.03%
#10 Arowana Arowana +10.03%
Coin of the day
Islamic Coin Islamic Coin
設定
言語
日本
通貨
USD
テーマ
Forza Innovations Inc. Forza Innovations Inc.

Forza Innovations Inc.

FORZ
株式のランク #40085
Forza Innovations Inc. specializes in health-tech wearable performance... Forza Innovations Inc. specializes in health-tech wearable performance solutions. Its flagship product line, the WarmUp series, comprises wearable back compression devices such as the J4 Sport, J4 X, and J4 Fitbelt. These devices are specifically designed to aid in muscle relaxation, warm-up, and to alleviate stiffness and soreness. The company adopted its current name, Forza Innovations Inc., in June 2021, having previously operated as Genesys Industries, Inc. Established in 2014, Forza Innovations Inc. is headquartered in San Diego, California.
株価
$0.0001
最終同期: 2026-08-12
時価総額
$252.18K
変化（1日）
0.00%
変化（1年）
0.00%
国
US
取引 Forza Innovations Inc. (FORZ)

カテゴリー

Healthcare
Forza Innovations Inc.（FORZ）の収益
Aug 2026 時点の収益 TTM: 0
Forza Innovations Inc. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Forza Innovations Inc. の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US